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SUMMARY
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The purpose of the Cosmos 2229 11 and 1/2 day mission was to begin experiments to
determine the suitability of the rhesus monkey as a surrogate for humans in space research. In
this study, experiments examining the effects of space flight on immunological responses of
rhesus monkeys were performed to gain insight into the effect of space flight on resistance to
infection. Experiments were performed on tissue samples taken from the monkeys before and
immediately after flight. Additional samples were obtained approximately one month after flight for
a post-flight restraint study. Two types of experiments were carried out throughout this study.
The first experiment examined the responsiveness of rhesus bone marrow cells to recombinant
human granulocyte/macrophage colony stimulating factor (GM-CSF). In the second experiment,
monkey peripheral blood and bone marrow cells were stained using a variety of antibodies
directed against cell surface antigenic markers. Human reagents that cross-reacted with monkey
tissue were utilized for the bulk of the studies. Results from both studies indicated that there were
changes in immunological function attributable to space flight. Bone marrow cells from flight
monkeys showed a significant decrease in their response to CSF-GM when compared to the
response of bone marrow cells from non-flight control monkeys. Antibody staining of both blood
and bone marrow cells from flight monkeys showed alterations in leukocyte subset distributions
when compared to antibody staining patterns of non-flight controls. These results suggest that
the rhesus monkey will be a useful surrogate for humans in future studies which examine the
effect of space flight on immune response, particularly when conditions do not readily permit
human study.
INTRODUCTION
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©ata from studies reported over the past several years have indicated that various
alterations in immunological parameters occur after space flight (Barone and Caren, 1984; Cogoli,
1981 and 1984; Durnova etaL, 1978; Gould etaL, 1987a; Konstantinova etaL, 1985; Lesnyak
and Tashputalov, 1981 ; Mandel and Balish, 1977; Sonnenfeld eta/, 1990; Talas et al., 1983 and
1984; Taylor et aL, 1983 and 1984). Immunological changes similar to those observed after
space flight have been reported in various ground base studies, including antiorthostatic
suspension of rats (Caren et aL, 1980; Gould and Sonnenfeld, 1987b; Rose et al., 1984;
Sonnenfeld, eta/.., 1982). These changes involve alterations in lymphoid organ size (Durnova et
al., 1976), alterations in the production of interferons (Talas etal., 1983 and 1984; Gould eta/.,
1987a), and alterations in lymphocyte activation (Cogoli et al., 1981 and 1984).
The 11.5 day Cosmos 2229 space flight attempted to further explore space flight effects
on immune response. Immunological parameters similar to those parameters affected in rats after
similar flights, including Cosmos 2044, were chosen for study in Cosmos 2229. Results from the
Cosmos 2044 study had shown that space flight inhibited the ability of GM-CSF to stimulate
colony formation in rat bone marrow cells, and altered various leukocyte subset population
distributions, such as the CD4+ and CD8+ cell subsets (Sonnenfeld et al., 1992). These studies
and recent ground-based studies establishing immunological techniques for handling rhesus
monkey cells (Sonnenfeld et al., 1993) made possible testing of the hypothesis that the rhesus
monkey could be used as a surrogate for humans in future studies. This could be of great
advantage, since rhesus monkey and human immune systems have been shown to be closely
related. The purpose of the current study was to further validate use of the rhesus monkey as a
model for humans in future space flight testing.
The areas of immunological importance examined in the Cosmos 2229 flight were
represented by two sets of studies. The first set of studies determined the effect of space flight
on the ability of bone marrow cells to respond to granulocyte/monocyte colony stimulating factor
(GM-CSF). GM-CSF is an important regulator in the differentiation of bone marrow cells of both
4monocyte/macrophage and granulocyte lineages and any change in the ability of these cells to
respond to GM-CSF can result in altered immune function (Waheed and Shadduck, 1979).
A second set of studies determined space flight effects on the expression of cell surface
markers on both spleen and bone marrow cells. Immune cell markers included in this study were
those for T-cell, B-cell, natural killer cell, and interleukin-2 populations. Variations from a normal
cell population percentage, as represented by these markers, can be correlated with alterations in
immunological function (Jackson and Warner, 1986). Cells were stained with fluorescein-labelled
antibodies directed against the appropriate antigens, and then analyzed using a flow cytometer.
MATERIALS AND METHODS
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Two juvenile male rhesus monkeys (Macacca mulatta) were born at the Soviet Primate
Cemer in Sukhumi, Georgia and sustained throughout the duration of studies reported in this
paper at the Institute of Biomedical Problems in Moscow, Russia. The monkeys were flown
under chair restraint for 11.5 days during the Cosmos 2229 (Bion 10) flight from December 19,
1992 to January 10, 1993. Details concerning flight conditions, condition of monkeys pre- and
post-flight, as well as maintenance procedures for all animals used in this study, are described in
the Mission Description section of this technical memorandum.
Tissue sampling from the monkeys for pre-flight studies occurred approximately 1.5
months prior to flight. Tissue sampling was also done at various time periods after flight, from 1 to
12 days post-flight recovery. Two types of tissue samples were obtained: peripheral blood and
bone marrow. Additional samples were obtained from monkeys for a post-flight study examining
the possible role of restraint in those effects observed after space flight. The restraint study was
carried out 40 days post-recovery for the same duration of time as the flight. Other controls
involved the testing of bone marrow and blood obtained from flight-pool monkeys as well as the
testing of bone marrow and blood samples from two standard vivarium control monkeys (#s 85
and 3224) at regular intervals throughout each experimental period. Results from the testing of
standard vivarium control monkeys indicated when changes in test values were due to a failure of
experimental procedure. The sampling schedule is given in the results section of this report.
Bone marrow samples were obtained through needle biopsy of the posterior of the head
of the humerus (left or right) of monkeys under Ketamine/Xylazine anesthesia. Each bone
marrow sample was transferred to a 15 ml polypropylene centrifuge tube containing McCoy's
medium (Gibco BRL, Grand Island, NY) supplemented with antibiotics, sodium bicarbonate,
hepes buffer, L-glutamine, and fungizone. Bone marrow cells were centrifuged and resuspended
in supplemented McCoy's medium with 10% FBS (as a washing step). Cell counts were
obtained on a hemocytometer, using trypan blue dye exclusion for determination of viability. One
x 105 bone marrow cells/mL were resuspended in a 2% methylcellulose solution prepared in
6supplemented McCoy's media containing 30% FBS (Shadduck and Nagabhushnam, 1971 ).
Medium for experimental group cultures contained a concentration of 40 ng/ml recombinant human
GM-CSF (a gift of Dr. Steven Gillis, Immunex Research and Development Corp, Seattle, WA).
The GM-CSF was from lot 620-028-5, and had a specific activity of at least 5 x 107 units/mg
protein. For each animal tested, five 35 mm tissue culture dishes, each containing 1 ml of the
bone marrow cell suspension, were set up for control ( - CSF) and for experimental ( + CSF)
groups. Dishes containing suspended cells were incubated in a 37"C incubator with 5% CO2
(Shadduck and Nagabhushanam, 1971). After 7 days of incubation, 10 microscope fields from
each petri dish were evaluated for the number of colonies formed, a colony represented by
aggregates of 50 or more cells (Sonnenfeld, etaL, 1990). The GM-CSF data was analyzed
using a pooled estimate of variance and linear contrast analysis.
The following procedure was implemented to evaluate cell surface antigenic markers on
bone marrow cells (Jackson and Warner, 1986). One x 106 bone marrow cells, suspended in
supplemented McCoy's media with 10% FBS, was allocated to each microcentdfuge tube. Cell
suspensions were centrifuged for 1.5 min at 1,000 x g, supernatant removed, and 5 #1 of the
appropriate antibody added to each microcentrifuge tube. Background values were taken into
account by including a microcentrifuge tube containing cells, but no antibody, for each animal
tested. Cells and antibody (or no antibody) were allowed to incubate at 4°C for 25 min.
Antibodies used in this study were obtained from Becton-Dickinson Immunocytochemistry
Systems, San Jose, CA, except as noted below:
1. Leu 2a (CD-8, cytotoxic T lymphocyte)
2. Leu 3a (CD-4, helper T lymphocyte)
3. Leu 4 (CD-3 signal transducer for T lymphocyte)
4. Leu 11 a (CD-16, Natural killer cell/monocyte)
5. Anti-human IgM (B cell - purchased from Sigma Chemical Co., St. Louis, MO)
6. Anti-monkey IgG (B cell - purchased from Organon-Teknika Corp. W. Chester, PA)
7. Anti-monkey IgG F(ab)' (B cell - purchased from Organon-Teknika Corp.)
9 Goat anti-rabbit IgG (Purchased from Accurate Chemical Co., Westbury, NY)
7No antibody added.
After the 25 minute incubation, red blood cells were lysed for 6 minutes at room
temF:_rature with one ml of lysing solution/microcentrifuge tube (8.26 g ammonium chloride, 1.00 g
potassium bicarbonate, 37 mg of tetrasodium EDTA brought to 1 L with distilled water, pH 7.4).
Cell suspensions were then centrifuged for 1.5 min at 1,000 x g, and resuspended in FTA buffer
(BBL Microbiology Systems, Cockeysville, MD), pH 7.4, containing 0.1% sodium azide. Cell
suspensions were again centrifuged for 1.5 min at 1,000 x g, supernatant removed, and cells
fixed by resuspension in 0.5 ml of 1% paraformaldehyde prepared in FTA buffer. The staining
procedure for peripheral blood was exactly the same as for bone marrow except that 20 I.dof
heparin-treated blood was placed into each microcentrifuge tube and then stained.
Fixed cells from blood and bone marrow staining were maintained at 4°C, flown to the
United States at this temperature, and later analyzed at the University of Louisville to determine
the presence of antigenic markers using a Profile II flow cytometer (Coulter Electronics, Hialeah,
FL). Lymphocytic and myelogenous regions were gated on three-part differentials using forward
vs. side scatter plots.
Statistical analysis of bone marrow cell response to GM-CSF was accomplished by
using a pooled estimate of variance in the hypothesis testing of differences between two group
means. Flow cytometry results from antibody stained peripheral blood and bone marrow cells
were analyzed using linear contrast and factorial anova. Alpha was set a priori at p < 0.05
RESULTS
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Effect of space flight on the response of bone marrow cells to GM-CSF
Bone marrow cells from some monkeys within the pool of flight animals showed a lower
than normal response to human GM-CSF prior to flight (Table 1). Bone marrow from monkeys
exposed to space flight showed decreases in the ability to form colonies in response to GM-CSF
when compared bone marrow cells from standard vivarium control monkeys (Table 2). As time
progressed, recovery towards the normal GM-CSF developed, but suppression of colony
formation occurred again at 12 days post landing (Table 2). There was also significant variability
in the response of bone marrow from standard vivarium control monkeys to GM-CSF across the
pre- and post-flight testing periods (figures 1,2, and 3). Except in the post-flight restraint study
(Tables 1,2, and 3), there was always an increase in colony formation if GM-CSF was present
in the cultures when compared to control cultures ( - CSF) from the same animal.
Effect of space flight on the percentage of cells expressing cell surface antigenic
markers
Results from antibody staining of peripheral blood and bone marrow were very similar in
the pattern of response. Data from anti-monkey IgG only rather than data from both this antibody
and the other positive control antibody used in the staining study, anti-monkey IgG F(ab')2, is
included since the data were very similar. All given cell population percentages have had
background values subtracted through gating against unstained cell populations. Prior to flight,
several of the flight pool animals showed significant differences in stained cell population
percentages for the different surface antigens (Tables 4-10). For all leukocyte surface markers
tested, a decreased expression of the surface antigens occurred immediately after flight (recovery
+ 1 day, and recovery + 2 days), followed by a shift toward more normal values at recovery + 3
days. A return to suppression occurred at recovery + 12 days (Tables 11-17). There was also
variability in the flow cytometry data from standard vivarium control monkeys within and across
pre- and post-flight testing periods (Tables 11-17).
9Effect _f postflight restraint on the percentage of cells expressing cell surface
antigenic markers
Flow cytometry data from the antibody staining of both peripheral blood leukocyte and
bone marrow have been included in the tables section because of differences in the response of
these two cells types. Restraint of the flight animals resulted in decreases in the percentage of
peripheral blood leukocytes carrying the CD-8 marker and in the percentage of bone marrow cells
carrying the HLA-DR marker (Tables 18-31). These were the only changes observed in the
response of flight animals to restraint, but restrained controls showed other alterations (Tables 18-
31).
DISCUSSION
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Results of the current study suggest that space flight affects immunological parameters of
the rhesus monkey. This study suggests that the bone marrow cell response to colony
stimulating factor, as well as leukocyte subset cell population distributions of both peripheral
blood and bone marrow leukocytes, were altered after space flight. It is worth noting that most
immunological parameters examined in Cosmos 2229 were suppressed for some period of time
after flight. Immunological results from Cosmos 2229 differed from previous Cosmos flights
involving rats in that the number of bone marrow colonies formed in response to colony
stimulating factor was depressed, but leukocyte population percentages found from antibody
staining showed both increases and decreases after flight (Sonnenfeld et aL, 1992). A number of
possible explanations can be given to account for comparative discrepancies between the
results of Cosmos 2229 and previous flights. Among these explanations are species difference
and differences in flight conditions which, regardless of species difference, may have had some
immunological impact. Further experimentation is required to answer these questions.
All immune parameters tested in the study of flight monkeys appeared to return towards a
more normal level by 3 days post- landing; however, by 12 days post-landing, these responses
were again suppressed. This second drop occurring after recovery could have been due to
stress on the monkeys due to increases in scientific testing and handling of the animals. There
were differences in the level, but not the pattern, of immune response observed in each of the
two flight monkeys. These differences may be explained by the dehydration and reduced food
intake experienced by one of the flight monkeys both during and immediately after flight.
There were experimental difficulties observed in both pre- and post- flight experiments.
First, there were unusual responses of bone marrow to GM-CSF and unusual leukocyte
phenotyping in some flight pool animals monkeys prior to flight support pre-flight levels of
immunosuppression (Sonnenfeld et aL, 1993). Explanations for the unusual pre-flight
immunological responses of the flight pool animals could include the nutritional status of these
monkeys, or immunosuppression caused by stresses from increased handling. Additionally,
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prer_;__[alconditions and nurturing of the monkeys could have had important influences on pre- and
pos_-fiight results. Second, there were differences across testing periods in the response of
star_dard vivarium control monkey bone marrow cells to GM-CSF as well as differences in the
resuits of cell population staining percentage. This variation from testing time to testing time has
not observed in previous studies (Sonnenfeld et al., 1993). Results from standard vivarium
control monkey samples were included as baseline values to insure that those changes
observed after flight were directly due to space flight and not to possible problems with
experimental procedure. Despite the changes in observed in these vivarium control values
across testing times, when differences between results from standard vivarium control and flight
animals occurred, they were of similar proportions. This allowed for interpretation of the flight data,
and reinforced the need for this type of standard vivarium control in future flight experiments.
After the flight, both flight animals were placed in flight chairs in an attempt to determine the
effect of restraint on immunological parameters measured in this study. Data from the study of the
response of bone marrow from restrained flight animals to GM-CSF were uninterpretable because
bone marrow taken from standard vivarium control monkeys at corresponding time periods in the
restraint study showed no response to GM-CSF. However, it appeared that restraint of the flight
animals resulted in only some of the immunological changes in leukocyte phenotypes that were
altered by space flight. Some of the restrained animals had changes in immune parameters that
were different from those observed after space flight. Therefore, restraint probably played some
small role in those immunological changes observed after space flight, but, certainly, was not
responsible for the majority of the changes which occurred after flight.
SUMMARY AND CONCLUSIONS
The current study indicates that exposure of rhesus monkeys to space flight resulted in
inhibition of the response of bone marrow cells to GM-CSF and depression of the percentage of
peripheral blood and bone marrow leukocyte antibody markers. B cells, bearing surface
immunoglobulin, appeared to be less affected than were T cells. As time progressed following
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landing, the flight monkeys appeared to recover their immune responses; however, post-flight
testing possibly contributed to a second drop in immunological response. Restraint appeared to
play some role in the effect of space flight on immune response, but restraint alone was not
responsible for all of the immunological changes observed after flight.
Despite experimental difficulties, immunological results from the Cosmos 2229 space flight
provide interesting new data suggesting that space flight indeed effects some immune responses
of rhesus monkeys. These results indicate there may be an effect of species difference when
comparing the immunological impact of space flight on monkeys and rats, as well as possible
effects of stress and microgravity. The importance of these and other factors having possible
immunological implications should be determined and taken into consideration for the design of
future studies involving space flight. Further experimentation is required to establish the degree to
which these and other factors are involved in changes resulting from space flight, mechanisms for
these changes, and possible measures which can be used to abrogate or mediate such
influences.
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Preflight Response of Bone Marrow Cells to GM-CSF
Animal # Condition Durinq Flight # Colonies - CSF # Colonies + CSF
85 Standard Vivarium Control 0 8
3224 0 6
151 Flight 5 25
906 3 2
476 Flight PoolCont_l 0 0
775 0 2
856 2 14
907 0 43
Statistical considerations:
Significance, p < 0.05, determined using a pooled estimate of variance for a two-tailed t-test.
Standard vivarium control monkeys (#s 85 and 3224)* vs standard vivarium control monkeys (#s
85 and 3224)**: 9.902 x 10.3 < 0.05.
Flight monkey (#151)* vs flight monkey (#151)**: 14.142 < 4.303
Flight pool control monkey (# 856)* vs flight pool control monkey (# 856)**: 8.49 > 4.303
Flight pool control monkey (#907)* vs flight pool control monkey (#907)**: 330.41 > 4.303
TABLE 2
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Postflight Response of Bone Marrow Cells to GM-CSF
Animal # Condition Durinq Flight # Colonies - CSF # Colonies + CSF
85 Standard Vivarium Control at R + 3 15 37
3224 19 41
151 Flight at R + 3 22 16
906 17 17
775 Flight Pool Control at R + 3 11 19
476 Flight Pool Control at R + 5 7 31
775 19 25
838 Flight Pool Control at R +10 11 14
1324 10 11
85 Standard Vivarium Control at R + 12 11 16
3224 5 13
151 Flight at R + 12 8 22
9O6 6 10
Stattistical considerations:
Significance, p < 0.05, determined using a pooled estimate of variance for a two-tailed t-test.
TABLE 2 - Continued
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Stanaard vivanum control monkeys at R + 3 (#s 85 and 3224)* vs standard vivarium control
monkeys at R + 3 (#s 85 and 3224)**: 8.07 x 10-3 < 0.05.
Standard vtvanum control monkeys at R + 3 (#s 85 and 3224)* vs standard vivarium control
monkeys at R + 12 (#s 85 and 3224)**: 5.13 x 10 -3 < 0.05.
Standard vivarium control monkeys at R + 3 (#s 85 and 3224)** vs flight pool control monkeys at
R + 10 (#s 85 and 1324)**: 4.39 x 10-3 < 0.05.
Standard vwanum control monkeys at R + 3 (#s 85 and 3224)** vs flight pool control monkeys at
R + 5 (#s 775 and 476)**: 0.0464 < 0.05.
Standard vivanum control monkeys at R + 12 (#s 85 and 3224)** vs flight pool control monkeys at
R + 5 (#s 775 and 476)**: 0.0283 < 0.05.
Standard vtvanum control monkeys at R + 3 (#s 85 and 3224)* vs flight pool control monkeys at
R + 10 (#s 85 and 1324)*: 0.0438 < 0.05.
Standard vwanum control monkeys at R + 3 (#s 85 and 3224)* vs flight monkeys at R + 12 (#s
151 and 906)*: 0.0233 < 0.05.
Standard vwartum control monkeys at R + 3 (#s 85 and 3224)** vs flight monkeys at R + 12 (#s
151 and 906)**: 0.034 < 0.05.
Standard vtvanum control monkeys at R + 12 (#s 85 and 3224)* vs flight monkeys at R + 3 (#s
151 and 906)*: 0.0493 < 0.05.
Standard vwartum control monkeys at R + 3 (#s 85 and 3224)** vs flight monkeys at R + 3 (#s
151 and 906)**: 4.15 x 10 °3 < 0.05.
Flight monkeys at R + 12 (#s 151 and 906)* vs flight monkeys at R + 3 (#s 151 and 906)*:
0.0217 < 0.05.
Flight pool control monkeys at R + 5 (#s 476 and 775)** vs flight pool control monkeys at R + 10
(#s 476 and 775)**: 0.0219 < 0.05.
Flight pool control monkeys at R + 10 (#s 838 and 1324)* vs flight monkeys at R + 12 (#s 151
and 906)*: 0.0443 < 0.05.
TABLE 2 - Continued
2O
Flight pool control monkeys at R + 10 (#s 838 and 1324)* vs flight monkeys at R + 3 (#s 151
and 906)*: 0.0359 < 0.05.
Flight pool control monkeys at R + 5 (#s 476 and 775)** vs flight monkeys at R + 3 (#s 151 and
906)**: 0.0317 < 0.05.
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TABLE3
Effectof PostflightRestrainton the Responseof BoneMarrowCells to GM-CSF
Animal# Condition # Colonies- CSF # Colonies+ CSF
85 StandardVivariumControl 5 7
3224 4 5
151 Flight+ Restraint 2 2
906 4 8
803 FlightPoolControl+ Restraint 8 5
907 8 10
588 VivariumControl 12 24
1417 6 7
*Significance,p < 0.05,comparedto standardvivariumcontrolgroup( - GM-CSF)
**Significance,p < 0.05,comparedto standardvivariumcontrolgroup( + GM-CSF)
Therewasno significance,p < 0.05,withingroupscomparing- GM-CSFto + GM-CSF.
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TABLE 4
Preflight Staining of Peripheral Blood with Anti-HLA-DR
Animal # Condition During Flight % Lymphoid Cells Stained
85 Standard Vivarium Control 28.1
3224 14.3
151 Flight 9.6
906 0
476 Flight Control Pool 7.2
775 4.7
803 0
856 0
858 0.1
892 0
907 2.5
1404 0.2
*Significance, p < 0.05, between standard vivarium control monkeys (#s 85 and 3224) and
individual flight monkeys
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TABLE 5
Preflight Staining of Peripheral Blood with Leu-2a (CD 8)
Animal # Condition During Flight % Lymphoid Cells Stained
85 Standard Vivarium Control 3.2
3224 8.8
151 Flight 14.3
906 0
476 Flight Control Pool 2.3
775 1.0
803 0
856 0.6
858 0
892 0
907 0.1
1404 0.3
*Significance, p < 0.05, between standard vivarium control monkeys (#s 85 and 3224) and
individual flight monkeys
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TABLE 6
Preflight Staining of Peripheral Blood with Leu-3a (CD 4)
Animal # Condition Durinq Flight % Lymphoid Cells Stained
85 Standard Vivarium Control 1.4
3224 0.8
151 Flight 5.8
906 0
476 Flight Control Pool 0.6
775 0.8
803 0
856 1.0
858 1.8
892 0
907 0.2
1404 0
*Significance, p < 0.05, between standard vivarium control monkeys (#s 85 and 3224) and
individual flight monkeys
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TABLE 7
Preflight Staining of Peripheral Blood with Leu-4 (CD 3)
Animal # Condition During Flight % Lymphoid Cells Stained
85 Standard Vivarium Control 0.6
3224 5.9
151 Flight 3.6
906 0
476 Flight Control Pool 1.2
775 0
803 0
856 3.1
858 1.6
892 0
907 0
1404 0.5
*Significance, p < 0.05, between standard vivarium control monkeys (#s 85 and 3224) and
individual flight monkeys
26
TABLE 8
Preflight Staining of Peripheral Blood with Leu-1 la (CD 16)
Animal # Condition During Flight % Lymphoid Cells Stained
85 Standard Vivarium Control 1.5
3224 3.6
151 Flight 9.2
906 0
476 Flight Control Pool 1.8
775 1.4
803 0
856 0.4
858 0.4
892 1.1
907 0.4
14O4 2.0
*Significance, p < 0.05, between standard vivarium control monkeys (#s 85 and 3224) and
individual flight monkeys
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TABLE 9
Preflight Staining of Peripheral Blood with Anti-Human IgM
Animal # Condition During Flight % Lymphoid Cells Stained
85 Standard Vivarium Control 50.1
3224 40.2
151 Flight 32.1
906 39.9
476 Flight Control Pool 56.6
775 64.3
803 56.6
856 38.7
858 81.4
892 51.9
907 63.3
1404 77.2
*Significance, p < 0.05, between standard vivarium control monkeys (#s 85 and 3224) and
individual flight monkeys
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TABLE 10
Preflight Staining of Peripheral Blood with Anti-Monkey IgG
Animal # Condition Durinq Flight % Lymphoid Cells Stained
85 Standard Vivarium Control 48.4
3224 69.8
151 Flight 63.5
906 32.4
476 Flight Control Pool 49.4
775 32.0
803 84.4
856 69.1
858 89.9
892 87.9
907 19.3
1404 71.8
*Significance, p < 0.05, between standard vivarium control monkeys (#s 85 and 3224) and
individual flight monkeys
TABLE11
29
Postflight Staining of Peripheral Blood with Anti-HLA-DR
Animal # Condition During Flight % Lymphoid Cells Stained
85 Standard Vivarium Control R + 3 0
85 R +12 3.1
3224 R + 3 2.0
3224 R + 12 0.2
151 Flight R + 2* 0
151 R + 3** 20.0
151 R + 12 0.2
906 R + 1 0
906 R + 2* 3.0
906 R + 3** 5.0
906 R + 12 0.2
476 Flight Control Pool R + 5*** 0
775 R + 5*** 11.0
838 R + 10 40.0
1324 R + 10 8.0
*Significance, p < 0.05, between standard vivarium control monkeys at R + 3 (#s 85 and 3224)
and R + 2 flight monkeys (#s 906 and 151 )
**Significance, p < 0.05, between standard vivarium control monkeys at R + 3 (#s 85 and 3224)
and R + 3 flight monkeys (#s 906 and 151)
***Significance, p < 0.05, between standard vivarium control monkeys at R + 3 (#s 85 and 3224)
and R + 3 flight monkeys (#s 476 and 775)
TABLE 12
30
PostflightStainingof PeripheralBloodwithLeu-2a(CD8)
Animal# ConditionDuringFlight % LymphoidCells Stained
85 StandardVivariumControl R+ 3 13.7
85 R+12 4.1
3224 R+ 3 0
3224 R+ 12 0
151 Flight R+ 2 0
151 R+ 3 19.6
151 R+ 12 0
906 R+ 1 0.3
906 R+ 2 1.2
906 R + 3 1.1
906 R + 12 0
476 FlightControlPool R+ 5 0
775 R+ 5 5.6
838 R+ 10 1.1
1324 R + 10 22.3
*Significance,p < 0.05,betweenstandardvivariumcontrolmonkeysat R+ 3 (#s 85and 3224)
andflightmonkeygroups
**Significance,p < 0.05,betweenstandardvivariumcontrolmonkeysat R + 12 (#s85and 3224)
andflightmonkeygroups
TABLE 13
31
Postflight Staining of Peripheral Blood with Leu -3a (CD 4)
Animal # Condition During Flight % Lymphoid Cells Stained
85 Standard Vivarium Control R + 3 9.5
85 R +12 1.3
3224 R + 3 4.1
3224 R + 12 0.2
151 Flight R + 2 5.2
151 R + 3 15.6
151 R + 12 0
906 R + 1 0.3
906 R + 2 0.8
906 R + 3 4.1
906 R + 12 0
476 Flight Control Pool R + 5 0.4
775 R + 5 2.8
838 R + 10 2.4
1324 R + 10 8.3
*Significance, p < 0.05, between standard vivarium control monkeys at R + 3 (#s 85 and 3224)
and flight monkey groups
**Significance, p < 0.05, between standard vivarium control monkeys at R + 12 (#s 85 and 3224)
and flight monkey groups
TABLE 14
32
Postflight Staining of Peripheral Blood with Leu-4 (CD 3)
Animal # Condition During Flight % Lymphoid Cells Stained
85 Standard Vivarium Control R + 3 11.3
85 R +12* 1.3
3224 R + 3 0
3224 R + 12" 0.2
151 Flight R + 2** 0
151 R + 3* 22.7
151 R + 12" 0
906 R + 1" 0
906 R + 2** 2.3
906 R + 3* 10.1
906 R + 12" 0
476 Flight Control Pool R + 5** 0.6
775 R + 5** 0
838 R + 10 5
1324 R + 10 14.6
*Significance, p < 0.05, between standard vivarium control monkeys at R + 3 (#s 85 and 3224)
and flight monkey groups
**Significance, p < 0.05, between standard vivarium control monkeys at R + 12 (#s 85 and 3224)
and flight monkey groups
TABLE15
33
Postflight Staining of Peripheral Blood with Leu-1 la (CD 16)
Animal # Condition During Flight % Lymphoid Cells Stained
85 Standard Vivarium Control R + 3 10.1
85 R +12 2.3
3224 R + 3 0
3224 R + 12 0.2
151 Flight R + 2 0
151 R + 3 7.2
151 R + 12 0
906 R + 1 0.8
906 R + 2 4.0
906 R + 3 3.5
906 R + 12 0.8
476 Flight Control Pool R + 5 0
775 R + 5 7.0
838 R + 10 0.8
1324 R + 10 12.7
*Significance, p < 0.05, between standard vivarium control monkeys at R + 3 (#s 85 and 3224)
and flight monkey groups
**Significance, p < 0.05, between standard vivarium control monkeys at R + 12 (#s 85 and 3224)
and flight monkey groups
TABLE16
34
PostflightStainingof PeripheralBloodwithAnti-HumanIgM
Animal# ConditionDuringFlight % LymphoidCellsStained
85 StandardVivariumControl R+ 3 54.4
85 R+12 33.3
3224 R+ 3 47.3
3224 R + 12 14.7
151 Flight R + 2 26.6
151 R + 3 72.3
151 R + 12 16.5
906 R+ 1 4.0
906 R+ 2 25.7
906 R+ 3 30.0
906 R+ 12 13.3
476 FlightControlPool R+ 5 19.0
775 R+ 5 49.6
838 R+ 10 45.2
1324 R+ 10 24.4
*Significance,p < 0.05, betweenstandardvivariumcontrolmonkeysat R + 3 (#s85and3224)
andflightmonkeygroups
**Significance,p < 0.05,betweenstandardvivariumcontrolmonkeysat R+ 12 (#s85and 3224)
andflightmonkeygroups
TABLE 17
35
Postflight Staining of Peripheral Blood with Anti-Monkey IgG
Animal # Condition During Flight % Lymphoid Cells Stained
85 Standard Vivarium Control R + 3 78.5
85 R +12 49.3
3224 R + 3 71.2
3224 R + 12 56.8
151 Flight R + 2* 56.3
151 R + 3 83.0
151 R + 12 58.0
906 R + 1 47.8
906 R + 2* 60.3
906 R + 3 65.8
906 R + 12 60.5
476 Flight Control Pool R + 5 59.8
775 R + 5 45.5
838 R + 10 37.3
1324 R + 10 46
*Significance, p < 0.05, between standard vivarium control monkeys at R + 3 (#s 85 and 3224)
and flight monkey groups
**Significance, p < 0.05, between standard vivarium control monkeys at R + 12 (#s 85 and 3224)
and flight monkey groups
TABLE18
36
Effectof Restrainton Stainingof PeripheralBloodwithAnti-HLA-DR
Animal# ConditionDurinqFlight % LymphoidCellsStained
85 StandardVivariumControl 27.5
3224 0.8
151 Flight+ Restraint 8.6
906 25.2
803 FlightPool+ Restraint 13.4
907 2.9
588 VivariumControl 16.7
1417 4.6
*Significance,p < 0.05,betweenstandardvivariumcontrolmonkeys(#s85 and3224)and
restraintmonkeygroupsor vivariumcontrolgroupmonkeys
TABLE19
37
Effectof Restrainton Stainingof BoneMarrowwithAnti-HLA-DR
Animal# ConditionDuringFlight % LymphoidCells Stained
85 StandardVivariumControl* 15.4
3224 16.6
151 Flight+ Restraint* 3.8
906 4.0
803 FlightPool+ Restraint* 12.6
907 9.0
588 VivariumControl 40.6
1417 39.3
*Significance,p < 0.05,betweenstandardvivariumcontrolmonkeys(#s85 and3224)and
restraintmonkeygroupsorvivariumcontrolgroupmonkeys
TABLE20
38
Effectof RestraintonStainingof PeripheralBloodwithLeu-2a(CD -8)
Animal# ConditionDuringFlight % LymphoidCellsStained
85 StandardVivariumControl 11.7
3224 0.9
151 Flight+ Restraint 4.8
906 11.1
803 FlightPool+ Restraint 21.8
9O7 O.8
588 VivariumControl 1.6
1417 2.2
*Significance,p < 0.05,betweenstandardvivariumcontrolmonkeys(#s85 and3224)and
restraintmonkeygroupsor vivariumcontrolgroupmonkeys
TABLE21
39
Effectof Restrainton Stainingof BoneMarrowwith Leu-2a(CD -8)
Animal# ConditionDuringFlight % LymphoidCells Stained
85 StandardVivariumControl 3.8
3224 10.1
151 Flight+ Restraint 0
906 0.8
803 FlightPool+ Restraint 0
9O7 2.8
588 VivariumControl 4.4
1417 0
*Significance,p < 0.05,betweenstandardvivariumcontrolmonkeys(#s85and 3224)and
restraintmonkeygroupsor vivariumcontrolgroupmonkeys
TABLE22
40
Effectof RestraintonStainingof PeripheralBloodwithLeu-3a(CD -4)
Animal# ConditionDurinqFlight % LymphoidCells Stained
85 StandardVivariumControl 6.2
3224 0
151 Flight+ Restraint 0
906 7.6
803 FlightPool+ Restraint 0
907 0
588 VivariumControl 0
1417 1.3
*Significance,p < 0.05,betweenstandardvivariumcontrolmonkeys(#s85and 3224)and
restraintmonkeygroupsor vivariumcontrolgroupmonkeys
TABLE 23
41
Effect of Restraint on Staining of Bone Marrow with Leu-3a (CD -4)
Animal # Condition During Flight % Lymphoid Cells Stained
85 Standard Vivarium Control 1.5
3224 0
151 Flight + Restraint 4.4
906 0.6
803 Flight Pool + Restraint 0
907 5.7
588 Vivarium Control 0
1417 0
*Significance, p < 0.05, between standard vivarium control monkeys (#s 85 and 3224) and
restraint monkey groups or vivarium control group monkeys
TABLE 24
42
Effect of Restraint on Staining of Peripheral Blood with Leu-4 (CD -3)
Animal # Condition During Flight % Lymphoid Cells Stained
85 Standard Vivarium Control 14.6
3224 0
151 Flight + Restraint 11.4
9O6 23.4
803 Flight Pool + Restraint 3.0
907 0
588 Vivarium Control 10.6
1417 26.8
*Significance, p < 0.05, between standard vivarium control monkeys (#s 85 and 3224) and
restraint monkey groups or vivarium control group monkeys
TABLE 25
43
Effect of Restraint on Staining of Bone Marrow with Leu-4 (CD -3)
Animal # Condition During Flight % Lymphoid Cells Stained
85 Standard Vivarium Control 21.4
3224 10.3
151 Flight + Restraint 39.9
906 13.7
803 Flight Pool + Restraint 17.6
907 18.5
588 Vivarium Control 13.5
1417 45.4
*Significance, p < 0.05, between standard vivarium control monkeys (#s 85 and 3224) and
restraint monkey groups or vivarium control group monkeys
TABLE 26
44
Effect of Restraint on Staining of Peripheral Blood with Leu-1 la (CD -16)
Animal # Condition During Flight % Lymphoid Cells Stained
85 Standard Vivarium Control 15.8
3224 0
151 Flight + Restraint 10.2
906 14.2
803 Flight Pool + Restraint 1.6
9O7 0
588 Vivarium Control 1.6
1417 2.6
*Significance, p < 0.05, between standard vivarium control monkeys (#s 85 and 3224) and
restraint monkey groups or vivarium control group monkeys
TABLE 27
45
Effect of Restraint on Staining of Bone Marrow with Leu-1 l a (CD -16)
Animal # Condition During Flight % Lymphoid Cells Stained
85 Standard Vivarium Control 6.6
3224 25.9
151 Flight + Restraint 8.9
906 30.9
803 Flight Pool + Restraint 10.0
907 16.3
588 Vivarium Control 13.0
1417 26.6
*Significance, p < 0.05, between standard vivarium control monkeys (#s 85 and 3224) and
restraint monkey groups or vivarium control group monkeys
TABLE 28
46
Effect of Restraint on Staining of Peripheral Blood with Anti-Human IgM
Animal # Condition During Flight % Lymphoid Cells Stained
85 Standard Vivarium Control 63.6
3224 74.6
151 Flight + Restraint 40.5
906 82.6
803 Flight Pool + Restraint 51.5
907 72.8
588 Vivarium Control 54.8
1417 62.7
*Significance, p < 0.05, between standard vivarium control monkeys (#s 85 and 3224) and
restraint monkey groups or vivarium control group monkeys
TABLE 29
47
Effect of Restraint on Staining of Bone Marrow with Anti-Human IgM
Animal # Condition During Flight % Lymphoid Cells Stained
85 Standard Vivarium Control 53.3
3224 71.7
151 Flight + Restraint 84.5
9O6 86.0
803 Flight Pool + Restraint 58.9
907 84.8
588 Vivarium Control 46.9
1417 83.9
*Significance, p < 0.05, between standard vivarium control monkeys (#s 85 and 3224) and
restraint monkey groups or vivarium control group monkeys
TABLE 30
48
Effect of Restraint on Staining of Peripheral Blood with Anti-Monkey IgG
Animal # Condition Durinq Flight % Lymphoid Cells Stained
85 Standard Vivarium Control 85.7
3224 79.2
151 Flight + Restraint 81.8
906 87.1
803 Flight Pool + Restraint* 68.5
9O7 72.9
588 Vivarium Control 58.5
1417 74.0
*Significance, p < 0.05, between standard vivarium control monkeys (#s 85 and 3224) and
restraint monkey groups or vivarium control group monkeys
TABLE31
49
Effectof RestraintonStainingof BoneMarrowwithAnti-HumanIgM
Animal# ConditionDuringFlight % LymphoidCells Stained
85 StandardVivariumControl 70.7
3224 70.6
151 Flight+ Restraint 76.1
906 51.2
803 FlightPool+ Restraint 36.8
907 74.4
588 VivariumControl 78.5
1417 42.3
*Significance,p < 0.05,betweenstandardvivariumcontrolmonkeys(#s85 and3224)and
restraintmonkeygroupsor vivariumcontrolgroupmonkeys
